InsidersTradesSigma
Follow the INTEGRAL DIAGNOSTICS LIMITED share price and the full directors' dealings record of the company, a publicly traded company based in Australia. Shares are quoted on AU AU, under the oversight of ASX. Market capitalisation: €770.4m. The latest transaction was filed on 1 July 2026 (Mixed). Among the most active insiders: Ian Kadish. The full history is accessible without an account.
Analysts rate INTEGRAL DIAGNOSTICS LIMITED Strong Buy (bullish), based on 13 analysts. Average price target: A$3.11.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
INTEGRAL DIAGNOSTICS LIMITED is a company listed on the XASX, specializing in the medical diagnostics sector. It provides medical imaging and diagnostic services to enhance patient care.